Follow us:

Microsoft Pri0

Welcome to Microsoft Pri0: That's Microspeak for top priority, and that's the news and observations you'll find here from Seattle Times technology reporter Matt Day.

July 17, 2007 at 4:25 PM

Biotechs cheer FDA funding proposal

A proposed boost in the U.S. Food and Drug Administration funding is making biotech companies smile — as the money could help speed up the grueling approval process for new treatments and devices.

On Tuesday, a Senate appropriations subcommittee voted to give the FDA a $1.75 billion budget — a $186 million increase.. That “represents the most significant increase in the FDA’s budget in recent memory,” said Jim Greenwood, president of the Biotechnology Industry Association.

He said:

“This will greatly enhance the ability of biotechnology pioneers to get life-enhancing and life-saving therapies out of research labs and into the hands of patients as quickly as possible.”

The FDA has been under increased pressure to step up its vigilance over the biotechnology and pharmaceutical industry in the wake of problems with approved drugs such as Merck’s Vioxx arthritis treatment. Both the House of Representatives and the Senate have recently approved bills strengthening the agency’s power.

Comments | More in Biotechnology

COMMENTS

No personal attacks or insults, no hate speech, no profanity. Please keep the conversation civil and help us moderate this thread by reporting any abuse. See our Commenting FAQ.



The opinions expressed in reader comments are those of the author only, and do not reflect the opinions of The Seattle Times.


The Seattle Times

The door is closed, but it's not locked.

Take a minute to subscribe and continue to enjoy The Seattle Times for as little as 99 cents a week.

Subscription options ►

Already a subscriber?

We've got good news for you. Unlimited seattletimes.com content access is included with most subscriptions.

Subscriber login ►
The Seattle Times

To keep reading, you need a subscription upgrade.

We hope you have enjoyed your complimentary access. For unlimited seattletimes.com access, please upgrade your digital subscription.

Call customer service at 1.800.542.0820 for assistance with your upgrade or questions about your subscriber status.

The Seattle Times

To keep reading, you need a subscription.

We hope you have enjoyed your complimentary access. Subscribe now for unlimited access!

Subscription options ►

Already a subscriber?

We've got good news for you. Unlimited seattletimes.com content access is included with most subscriptions.

Activate Subscriber Account ►